Skip to content
Insider tapeFilings through Fri, Oct 2

Kathryn Guarini

Director at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $660K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 3SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 400 $850.00 $340K -14.5%
Aug 12SEC REGNRegeneron Pharmaceuticals, Inc. Sell Plan 400 $800.00 $320K -9.2%
  • Sell

    Director Kathryn Guarini sold $340K of REGN at $850.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kathryn Guarini sold $320K of REGN at $800.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.